Although we reported the effect of BMP-2, it may be possible that some other factors secreted by BM-hMSCs underlie their therapeutic effects in PCOS—namely, inhibition of theca cell proliferation, androgen production, and inflammatory markers. Here, BMP2 is linked to polycystic ovary syndrome.